EMA committee recommends approval of Eisai & Biogen’s lecanemab to treat early Alzheimer’s disease: Tokyo Saturday, November 16, 2024, 13:00 Hrs [IST] Eisai Co., Ltd. and Biog ...
A single course of newly approved Alzheimer's drug donanemab-azbt, the second medicine available in Japan targeting proteins in the brains of sufferers of the debilitating disease, will cost 3.08 ...
Lecanemab is the first treatment for Alzheimer’s disease licensed for use in Great Britain that shows some evidence of ...
A groundbreaking medication designed to delay the onset of Alzheimer's has received approval for use within the EU. The drug, ...
Those with one copy are at increased risk too. Leqembi, which is developed by the Japanese pharmaceutical company Eisai and ...
Power discoms have provided electricity connections to 6,791 of the 10,802 applicants living in Delhi's unauthorised colonies following Lieutenant Governor V K Saxena's intervention, the Raj Niwas ...
When Labour took power in July it inherited an economy that had taken a beating but was starting to recover at speed. Not anymore.
Yet another rare oarfish has washed up on the coast of San Diego County in Southern California from the deep sea. The "doomsday" fish was found by Scripps Institution of Oceanography researchers at ...